Disruption of normal stem cell function and transmission of myelodysplastic syndrome by self-renewal of committed myeloid lineage cells.

IF 5.9 2区 医学 Q1 CELL & TISSUE ENGINEERING
Yang Jo Chung, Ryan Bertoli, Dengchao Cao, Robert L Walker, Yuelin Jack Zhu, Paul Meltzer, Peter D Aplan
{"title":"Disruption of normal stem cell function and transmission of myelodysplastic syndrome by self-renewal of committed myeloid lineage cells.","authors":"Yang Jo Chung, Ryan Bertoli, Dengchao Cao, Robert L Walker, Yuelin Jack Zhu, Paul Meltzer, Peter D Aplan","doi":"10.1016/j.stemcr.2025.102571","DOIUrl":null,"url":null,"abstract":"<p><p>The ineffective hematopoiesis of myelodysplastic syndrome (MDS) suggests that hematopoietic stem and progenitor cells (HSPCs) are defective. Here, we demonstrate that NUP98::HOXD13 (NHD13) MDS mice have significantly decreased functional HSPCs. Moreover, in contrast to wild-type (WT) bone marrow (BM), lineage-positive (Lin<sup>+</sup>) BM cells from NHD13 mice have self-renewal potential. Specific subsets of NHD13 Lin<sup>+</sup> cells that express B220 and Kit antigens were able to self-renew and generate MDS in WT recipients. Although this unique B220<sup>+</sup>Kit<sup>+</sup> phenotype could be found in WT as well as NHD13 BM, the population was markedly increased in NHD13 BM. Further characterization using Mac1 and Gr1 markers revealed that both Mac1<sup>+</sup>Gr1<sup>+</sup>B220<sup>+</sup>Kit<sup>+</sup> and Mac1<sup>-</sup>Gr1<sup>-</sup> B220<sup>+</sup>Kit<sup>+</sup> populations showed self-renewal and led to an MDS phenotype in WT recipients. Taken together, these findings demonstrate that as normal hematopoiesis derived from typical HSPCs decreases in NHD13 mice, committed hematopoietic progenitor cells proliferate, self-renew, and initiate MDS.</p>","PeriodicalId":21885,"journal":{"name":"Stem Cell Reports","volume":" ","pages":"102571"},"PeriodicalIF":5.9000,"publicationDate":"2025-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Stem Cell Reports","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.stemcr.2025.102571","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CELL & TISSUE ENGINEERING","Score":null,"Total":0}
引用次数: 0

Abstract

The ineffective hematopoiesis of myelodysplastic syndrome (MDS) suggests that hematopoietic stem and progenitor cells (HSPCs) are defective. Here, we demonstrate that NUP98::HOXD13 (NHD13) MDS mice have significantly decreased functional HSPCs. Moreover, in contrast to wild-type (WT) bone marrow (BM), lineage-positive (Lin+) BM cells from NHD13 mice have self-renewal potential. Specific subsets of NHD13 Lin+ cells that express B220 and Kit antigens were able to self-renew and generate MDS in WT recipients. Although this unique B220+Kit+ phenotype could be found in WT as well as NHD13 BM, the population was markedly increased in NHD13 BM. Further characterization using Mac1 and Gr1 markers revealed that both Mac1+Gr1+B220+Kit+ and Mac1-Gr1- B220+Kit+ populations showed self-renewal and led to an MDS phenotype in WT recipients. Taken together, these findings demonstrate that as normal hematopoiesis derived from typical HSPCs decreases in NHD13 mice, committed hematopoietic progenitor cells proliferate, self-renew, and initiate MDS.

骨髓系细胞自我更新对正常干细胞功能的破坏和骨髓增生异常综合征的传递。
骨髓增生异常综合征(MDS)的无效造血提示造血干细胞和祖细胞(HSPCs)存在缺陷。在这里,我们证明了NUP98::HOXD13 (NHD13) MDS小鼠显著降低了功能性HSPCs。此外,与野生型(WT)骨髓(BM)相比,来自NHD13小鼠的谱系阳性(Lin+)骨髓细胞具有自我更新潜力。表达B220和Kit抗原的NHD13 Lin+细胞的特定亚群能够在WT受体中自我更新并产生MDS。虽然这种独特的B220+Kit+表型可以在WT和NHD13 BM中发现,但在NHD13 BM中种群明显增加。利用Mac1和Gr1标记进一步表征发现,Mac1+Gr1+B220+Kit+和Mac1-Gr1- B220+Kit+群体都表现出自我更新,并导致WT受体出现MDS表型。综上所述,这些发现表明,当NHD13小鼠中来自典型HSPCs的正常造血功能减少时,承诺的造血祖细胞增殖、自我更新并启动MDS。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Stem Cell Reports
Stem Cell Reports CELL & TISSUE ENGINEERING-CELL BIOLOGY
CiteScore
10.50
自引率
1.70%
发文量
200
审稿时长
28 weeks
期刊介绍: Stem Cell Reports publishes high-quality, peer-reviewed research presenting conceptual or practical advances across the breadth of stem cell research and its applications to medicine. Our particular focus on shorter, single-point articles, timely publication, strong editorial decision-making and scientific input by leaders in the field and a "scoop protection" mechanism are reasons to submit your best papers.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信